Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma

Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma

Constitutional mismatch repair deficiency (CMMRD) is a cancer predisposition syndrome associated with the development of hypermutant pediatric high-grade glioma, and confers a poor prognosis. While therapeutic histone deacetylase (HDAC) inhibition of diffuse intrinsic pontine glioma (DIPG) has been...

Full description

Bibliographic Details
Main Authors: Alyssa Noll, Carrie Myers, Matthew C. Biery, Michael Meechan, Sophie Tahiri, Asmitha Rajendran, Michael E. Berens, Danyelle Paine, Sara Byron, Jiaming Zhang, Conrad Winter, Fiona Pakiam, Sarah E.S. Leary, Bonnie L. Cole, Evangeline R. Jackson, Matthew D. Dun, Jessica B. Foster, Myron K. Evans, Siobhan S. Pattwell, James M. Olson, Nicholas A. Vitanza
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Diffuse intrinsic pontine glioma (DIPG)
Hypermutant
Mismatch-repair (MMR)
Histone deacetylase inhibitor (HDACi)
Quisinostat
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558623000465

Internet

http://www.sciencedirect.com/science/article/pii/S1476558623000465

Similar Items